HALO
Halozyme Therapeutics, Inc. · Healthcare
SVP and Chief Technical Officer Michael J. Labarre sold $365K of Halozyme Therapeutics, Inc.
Sold$365,200
$36.52Price
10,000Shares
−6%Stake
What HALO did after the filing
- The stock from Tue, Oct 17 close, $37.56
- +2.5%
- S&P 500, same days
- +4.3%
Measured over 30 trading days, to the Nov 29 close.
Traded Tue, Oct 17. Filed Tue, Oct 17, 3:28 PM ET, during the session. Returns use the Oct 17 close and the Nov 29 close. Not investment advice.